ArticleTherapeutic advances in medical oncology2025

Exceptional response to TROP2 inhibition with sacituzumab govitecan in a patient with small cell carcinoma of the breast: a case report.

Kasey C Fitzsimmons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.